NeurologyLive Friday 5 — April 17, 2020
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending April 17, 2020.
Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
1: Diet Associated With Lower Risk of Cognitive Impairment
Consumption of whole fruits, vegetables, whole grains, nuts, legumes, fish and olive oil, as well as reduced consumption of red meat and alcohol was observed to assist in preserving cognitive function.
2: Robert E. Shapiro, MD, PhD: Migraine Care in the Era of COVID-19
The professor of neurology at the University of Vermont Larner College of Medicine and founding president of the Alliance for Headache Disorders Advocacy discussed the special article he and colleagues published in the Headache journal on migraine care.­­
3: Recent Approvals for MS: Cladribine and Diroximel Fumarate
The panel outlines data from the phase 3 ORACLE MS and CLARITY extension trials of cladribine and the phase 3 EVOLVE-MS-2 trial of these 2 drugs recently FDA approved for multiple sclerosis.
4: Mind Moments Podcast: Innovation in the Parkinson Disease Pipeline
"Mind Moments," a podcast from NeurologyLive, brings you an exclusive interview with Fernando Pagan, MD.
5: What Role Does Age Play in Multiple Sclerosis?
The director of the Multiple Sclerosis Program at Cleveland Clinic Lou Ruvo Center for Brain Health discussed the correlation between age and disease duration in MS, as well as what was learned from a subanalysis of the EXPAND study of siponimod.
